Full View

MDR1, Chemotherapy and chromatin remodeling

EK Baker, A El-Osta - Cancer biology & therapy, 2004 - Taylor & Francis
The development of multidrug resistance (MDR) in cancer can severely impede the efficacy
of chemotherapy treatment. P-glycoprotein (Pgp) overexpression, encoded by the MDR1 …
被引用次数：70 相关文章

MDR1, chemotherapy and chromatin remodeling.

EK Baker, A El-Osta - Cancer Biology & Therapy, 2004 - europepmc.org
The development of multidrug resistance (MDR) in cancer can severely impede the efficacy
of chemotherapy treatment. P-glycoprotein (Pgp) overexpression, encoded by the MDR1 …

[引用][C] MDR1, Chemotherapy and chromatin remodeling

EK Baker, A El-Osta - Cancer Biology & Therapy, 2004 - cir.nii.ac.jp
<i>MDR1</i>, Chemotherapy and chromatin remodeling | CiNii Research CiNii 国立情報学
研究所 学術情報ナビゲータ[サイニィ] 詳細へ移動 検索フォームへ移動 論文・データをさがす 大学 …

MDR1, chemotherapy and chromatin remodeling

EK Baker, A El-Osta - Cancer Biology and Therapy, 2004 - research.monash.edu
The development of multidrug resistance (MDR) in cancer can severely impede the efficacy
of chemotherapy treatment. P-glycoprotein (Pgp) overexpression, encoded by the MDR1 …
[PDF] researchgate.net

[PDF][PDF] Emma K. Baker Assam El-Osta

Cancer Biology & Therapy, 2004 - researchgate.net
The development of multidrug resistance (MDR) in cancer can severely impede the efficacy
of chemotherapy treatment. P-glycoprotein (Pgp) overexpression, encoded by the MDR1 …

MDR1, chemotherapy and chromatin remodeling

EK Baker, A El-Osta - Cancer biology & therapy, 2004 - pubmed.ncbi.nlm.nih.gov
The development of multidrug resistance (MDR) in cancer can severely impede the efficacy
of chemotherapy treatment. P-glycoprotein (Pgp) overexpression, encoded by the MDR1 …